RHA2, RHA3, and RHA4 dermal fillers
FDA premarket approval P170002/S007 · decided 2019-12-13
Approval details
- PMA number
- P170002
- Supplement
- S007
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- RHA2, RHA3, and RHA4 dermal fillers
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Teoxane S.A.
- Date received
- 2019-11-13
- Decision date
- 2019-12-13
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Geneva
- Statement
- Change in the receiving procedure for raw material Hyaluronic Acid.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.